Some results of studying the effectiveness of vaccination against hepatitis B
https://doi.org/10.22625/2072-6732-2020-12-2-71-78
Abstract
With the increase in period of time from the beginning of vaccination against hepatitis B the relevance of the question about the duration of post-vaccination immunity increases.
The study has aimed to evaluate post-vaccination humoral immunity to hepatitis b virus 3–9 and 10–17 years after vaccination.
Materials and methods. The level of antibodies to HBsAg was studied in 25 children aged 3–4 years and 104 adolescents aged 16–17 years who were vaccinated in the first year of life, as well as 79 adults who were vaccinated at different times over 17 years. Vaccination was carried out according to the scheme: 0-1-6 months with different recombinant vaccines. The test systems “Vectonvsad-antibodies” produced by JSC “Vector-best” were used for the study.
Results. Antibody titers below 10 IU / l were found in 49,0±4,9% of adolescents and 50,0±8,6% of adults vaccinated over 10–17 years, 56,4±8,0% of adults vaccinated over 3–9 years, and 60,0±9,8% of children vaccinated over 3–4 years prior to the study. Antibodies in titers above 10 mIU/ml were detected only in isolated cases. No cases of hepatitis b virus infection or transmission were registered
among the surveyed individuals.
The low level of anti-HBs was not associated with specific names of vaccines and their storage conditions, with longer intervals between vaccinations. There was a slight decrease in the immune response in people over 40 years of age. The significant proportion of people who do not have a protective level of anti-HBs among those who have been vaccinated three times, identified in our and a number of other published studies, requires further study. In General, among the population of the Republic, the incidence of all forms of infection in the last decade against the background of mass vaccination has had a pronounced downward trend.
About the Author
L. V. Rubis
Petrozavodsk State University;
City outpatient polyclinic № 4
Russian Federation
Petrozavodsk
Russian Federation
Petrozavodsk
References
1. Infectious Morbidity in the Russian Federation, 1913-2002// the Collection of statistical and analytical materials. M. Federal Service for Supervision of Consumer Rights Protection and Human Welfare. –M. – 2003. – P. 69
2. Infectious and Parasitic Morbidity in the Russian Federation in January-December 2018. Statistical Materials // http://rospotrebnadzor.ru/activities/statistical-materials/statistic_detail.php?ID=11277 &sphrase_id=1643918
3. Semenenko, T. A. Immune response during vaccination against hepatitis B in persons with immunodeficiency conditions / T. A. Semenenko / / Epidemiology and vaccination. 2011. – No. 1 (56) – P. 51-58
4. Leuridan, E. Hepatitis B and the Need for a Booster Dose / E. Leuridan, P. Van Damm // Clin. Infect. Dis. –2011. № 53. – Р. 68-75.
5. Banatvala, J.E. Hepatitis B vaccine – do we need boosters? / J.E.Banatvala, P.Van Damme // J. Viral. Hepat. –2003. – V. 10 (1). –P. 1-6
6. Wang, R.X. Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination / R.X.Wang, G.J.Boland, J.van Hattum, G.C. de Gast // World J. Gastroenterol. – 2004. – V.10 (2). – P.260-263
7. Hudu, S.A. Antibody and Immune Memory Persistence Post Infant Hepatitis B Vaccination /S.A. Hudu, Y.A. Malic, M.T.Taib, et al. // Patient Preference and Аdherence – 2013. – No 7. – P. 981-986
8. Gara, N. Durability of Antibody Response Against Hepatitis B Virus in Healthcare Workers Vaccinated as Adults / N. Gara, A. Abdalla, E. Rivera, et al. // Clin. Infect. Dis. – 2015. – Feb 15;60 (4):505-13. DOI: 10.1093/cid/ciu867. Epub 2014 Nov
9. WHO. Hepatitis b vaccines: who position paper-July 2017./ WHO // weekly epidemiological Bulletin – 2017. – №27 (92). Р.369-392. http:// www.who.inf/wer
10. Yoshioka, N. Durability of Immunity by Hepatitis B Vaccine in Japanese Health Care Workers Depends on Primary Response Titers and Durations / N.Yoshioka, M. Deguchi, H. Hagiya // PLOS ONE. – Nov.–2017. –DOI:10.1371/journal.pone.0187661
11. Medunitsyn, N. V. Personal and collective immunity during vaccination /N. V. Medunitsyn, Yu. V. Olefir, V.A. Merkulov, V. P. Bondarev// Biopreparations. Prevention, diagnosis, treatment – 2016. –Т.16. – No 4. – P.195-207
12. Asratyan, A. A. Assessment of the intensity and duration of post-vaccination immunity against hepatitis B in medical personnel of a major drug treatment hospital / A. A. Asratyan, Yu. b. Novikova, T. R. Bakhshinyan, P. N. Dmitriev // Epidemiology and vaccine prevention. – 2011. – No 3 (58) – P. 64-69
13. Shulgina N. I. Assessment of the duration and intensity of post-vaccination humoral immunity to hepatitis B in persons of decreed groups / N. I. Shulgina // Epidemiology and vaccination. – 2011. – No 1 (56) – С. 68-73
14. Akimkin, V. G., Epidemiological and immunological efficiency of vaccination of medical workers against hepatitis B / V. G. Akimkin, T. A. Semenenko // Epidemiology and vaccination. – 2016. – Vol.16. No. 3 (94).– P. 12-16
15. Kalinina, Z. P. On Post-vaccination Immunity Against Hepatitis B Among Health Care Workers of St. Petersburg / Z.P. Kalinina, M. G. Darina, K. N. Movchana // Infection and Iimmunity. – 2015. – Vol.5. No. 1. –P. 89-92.
16. Shakhgildyan, I. V. Parenteral viral hepatitis (epidemiology, diagnosis, prevention) / I. V. Shakhgildyan, M.I. Mikhailov, G. G. Onishchenko // M. – 2003. –P. 88-89, 271
17. Shakhgildyan, I. V. The Results of Studying the Effectiveness of Mass Vaccination Against Hepatitis B In Selected Regions of the Russian Federation / I. V. Shakhgildyan, P. A. Khukhlovich, O. N. Ershova, etc. // Biological Products. Prevention, Diagnosis, Ttreatment. – 2010. – No 3 (39). – P. 29-30
18. Feldblyum, I. V. Vaccinal Prevention of Hepatitis B in Russia: Experience of Use Domestic Medical Immunobiological Preparations / I. V. Feldblyum //Epidemiology and vaccine prophylaxis. – 2012. – No 4 (65). – P. 61-67
19. Snegirevа, I. I. The Interchangeability of the Vaccines /I. I. Snegirev, K. E. Zatolokina, M. A. Dharmastala, etc. // Successes of Modern Natural Science. – 2015. – No. 8. – P. 43-47.
20. Shulakova, N. I. Epidemiological and immunological effectiveness of mass vaccination of the Russian population against hepatitis B /N. I. Shulakova // author’s abstract dis. – 14.02.02 – Еpidemiology. – Moscow. – 2017. – 209 с.
21. Yrysova, M. B. Post-Vaccination Screening of the Immunological Effectiveness of Vaccination Against Hepatitis B the Risk Groups for Iinfection (Health Care Workers, Prisoners) in the City of Bishkek / Yrysova M. B. // Science and New Technologies. – 2009. – No. 7. – P. 41-43
22. Kozhanova, T. V. Evaluation of Immunological Effectiveness of Mass Vaccination Against Hepatitis B / T. V. Kozhanova, V. V. Luchkina, K. K. Kyureghyan, etc. // Medical Virology. – 2014 – vol. 28I (1). – P. 16-25
23. Korovkin A. S. Comparative Characteristic of Modern Immune-enzyme Test-systems for Determination of Specific Activity of Vaccines Against Hepatitis B / A. S. Korovkin // author’s abstract dis. – 03.02.02. – Virology. – Koltsovo. – 2011. http://www.dissercat.com/content/sravnitelnaya-kharakteristika-sovremennykh-immunofermentnykh-test-sistemdlya-opredeleniya-s#ixzz5e1fbjohz
24. Rusanovich, A.V. Evaluation of the effectiveness of specific immunoprophylaxis of viral hepatitis B among medical workers / A.V. Rusanovich, M. A. Chernovetsky, M. I. Rimzha // World of viral hepatitis. – 2004. – No. 5. – P.7.
25. Shilova, I. V. Evaluation of long-term effectiveness of immunization against hepatitis B within the National vaccination calendar / I. V. Shilova, L. G. Goryacheva, S. M. Harit // Children’s infections. – 2017. – vol.16. – No. 4. – Р. 49-51
26. Shchukina, I. A. Immunological effectiveness of vaccination of medical personnel and children of a closed institution against hepatitis B with the «Engerix B» vaccine / I. A. Shchukina, I. A. Khodyakova, R. I. khitrova, etc. // World of viral hepatitis. – 2004. – No 5. – Р. 11.
27. Kiselev, S. V. Features of Formation of Postvaccinal Immunity to Viral Hepatitis “B” in Persons of Dangerous professions in Modern Conditions / S. V. Kiselev, I. A. Korolev // Scientific and Medical Bulletin of the Central Chernozem Region. –2017. – 0 70. – P. 26-29
28. Safyanova, T. V. Duration of Postvaccinal Immunity Against Viral Hepatitis B In the Population of the Altai Territory / T. V. Safyanova, V. I. Orlov, N.V. Lukyanenko // Medical Almanac. – 2010. – No. 3 (12 ). – P. 134-136
29. Penkina, T. V. the Breadth of the prevalence of hepatitis b markers among the medical staff of a multi-specialty hospital and the determination of the intensity of post-vaccination immunity / T. V. Penkina, T. M. Chupyra, T. Yu. Gurbatova, etc. /
30. / World of viral hepatitis. – 2006. – No. 6. – Р. 11–17.
31. Bektimirov, T. A. Successes and Problems of Hepatitis B Vaccination in the World / T. A. Bektimirov// Vaccination. News of Vaccination. –2001.– No.3 (15). – P.4-5
32. Eremeeva, J. G. analysis of the effectiveness of specific prevention of hepatitis In at risk / J. G. Eremeev, V. H. Fazylov, E. R. Manapova, F. M. Yakupova // Epidemiology and infectious diseases – 2019. – No 3. – С.39-46
33. Romanenko V. V., Experience of Implementation of “School Program”of Vaccine Prophylaxis of GV in Sverdlovsk Region / V. V Romanenko., I. O. Kuznetsova, h A. I. Yurovskik, etc. // World of Viral Hepatitis. –2000. – No. 2. – P. 9-10.
34. Vaccines and Vaccination: National Leadership / edited by V. V. Zverev, B. F. Semenov, R. M. Khaitova //M. – GEOTAR-Media. –2011. – 485 p.
35. Chulanov, V. P. Modern View on the Problem of Choosen a vaccines Against Hepatitis B / V. P. Chulanov, T. A. Semenenko. V. I., Karandashov etc. //Epidemiology and Vaccination. – 2017. – No 4 (95). –C. 22-27
Review
For citations:
Rubis L.V. Some results of studying the effectiveness of vaccination against hepatitis B. Journal Infectology. 2020;12(2):71-78. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-2-71-78
Views:
2000
.png)
.png)
Email this article 